Article
21 May 2026
Supreme Court Leaves Price-Anderson Act Split In Place
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
28 Apr 2026
DOJ Announces Controlled Substances Act Scheduling Changes For FDA-Approved Marijuana And State-Licensed Medical Marijuana Products
Article
07 Apr 2026
A New Era For Fraud Prosecutions At DOJ
Article
18 Mar 2026
Consumer Protection — Still Open For Business
Article
16 Mar 2026
The American Bar Association's Criminal Justice Section White Collar Crime Institute
Article
09 Mar 2026
SCOTUS Tariff Decision – Refunds, Impacts, And Strategic Considerations
Article
02 Jan 2026
One Year After Corner Post, Has The Litigation Tsunami Arrived?
Article
02 Jan 2026
From ALJs To Article III: Post-Jarkesy Litigation Over The Scope Of The Jury-Trial Right
Article
02 Jan 2026
Challenging Federal Government Actions After Trump v. CASA: New Limits And Open Pathways
Article
01 Jan 2026
Supreme Court’s Tariffs Ruling Answers Some Major Questions, Leaves Others Open
Article
12 Dec 2025
DOJ Issues Sweeping New Domestic Terrorism Directive: What The Attorney General's December 4 Memorandum Means For You
Article
12 Nov 2025
Recent Prosecutions Reflect New DOJ FCPA Guidelines
Article
30 Sep 2025
Turning Powerful Post 9-11 Counterterrorism Tools Onto Domestic Policy Targets
Article
11 Sep 2025
Transparency So Radical It Overlooks Law And Tradition: FDA Releases Complete Response Letters For Unapproved Drugs
Article
25 Aug 2025
The Demise Of FDA's Administrative Summary Judgment Standard: Lessons From Vanda v. FDA
Article
08 Aug 2025
DOJ Issues Sweeping Guidance On DEI Programs